Nonprofit Born From Ashes of 23andMe Hires Former Pfizer Heavyweight as GC

The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...

Regeneron Pharmaceuticals: Is Wall Street Finally Paying Attention?

So, Regeneron's revenue rose 1.9% from $3.68 billion in Q2 2025 to $3.75 billion, beating consensus estimate by $160 million ...
FiercePharma

Regeneron pledges $2B to convert former magazine factory into drug plant: NY governor

In a bid to deepen its manufacturing foothold in the U.S., Regeneron Pharmaceuticals in April pledged production and infrastructure investments surpassing $7 billion across North Carolina and its ...
FiercePharma

Regeneron wins 2 Eylea nods, ramping up competition with Roche

After months of back-and-and forth with the FDA and a third-party manufacturer, Regeneron has secured two long-awaited approvals for Eylea HD, gaining a new indication and a more flexible dosing ...
Benzinga.com

Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...
Morningstar

Regeneron Gets FDA Approval for Eye Treatment Eylea

Regeneron Pharmaceuticals received approval from the U.S. Food and Drug Administration for its eye treatment Eylea HD. The approval is for Eylea to treat macular edema following retinal vein occlusion ...
Seeking Alpha

Regeneron Pharmaceuticals, Inc. (REGN) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

[indiscernible] of Citi Global Healthcare Conference. My name is Geoff Meacham, I'm the senior biopharma analyst here. We're thrilled today to have Regeneron. And speaking on behalf of Regeneron, we ...

23andMe Research Institute Appoints John McLeod General Counsel and Chief Risk Officer

PALO ALTO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, ...
Wall Street Journal

They Found Relatives on 23andMe—and Asked for a Cut of the Inheritance

When Carmen Thomas was growing up in Boston, her mom told her that her absent dad’s name was Joe Brown. So when she sent a saliva sample to 23andMe in her 20s and got a match with a Brown, she was ...
Hosted on MSN

Regeneron downgraded at Morgan Stanley on valuation level

Morgan Stanley has downgraded Regeneron Pharmaceuticals (REGN) to equal-weight from overweight saying that the stock is fairly valued. The bank maintained its price target of $767 (~3% upside based on ...
Hosted on MSN

Regeneron gets EU nod for expanded approval of Libtayo

Regeneron Pharmaceuticals (REGN) has received approval from the European Commission for Libtayo (cemiplimab), to be used as an adjuvant treatment for adults with cutaneous squamous cell carcinoma ...
Law

Life360 Taps Expedia Vet as General Counsel

Matthew Cullen is joining the company as it racks up rapid growth, with monthly active users nearly doubling over the last three years. Matt Cullen is taking the legal reins of Life360 as the Bay Area ...